The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products.
Eckert & Ziegler was founded in 1997 as a holding company.
1997
Served areaWorldwide
Headcount828
HeadquartersRobert-Rössle-Straße 10, 13125 Berlin – Germany
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
30.08.23 | Eckert, Dr. Andreas | Supervisory board | Sell | EUR 1,526,400.00 |
30.08.23 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | EUR 1,526,400.00 |
11.08.23 | Perschmann, Frank | Supervisory board | Buy | EUR 16,600.00 |
13.01.23 | NEON Equity AG | Close relation | Buy | EUR 2,115.00 |
12.01.23 | Blunck, Dr. Thomas | Board | Sell | EUR 57,402.00 |
12.01.23 | Blunck, Dr. Thomas | Board | Sell | EUR 32,160.00 |
11.01.23 | Bouterfa, Dr. Hakim | Board | Buy | EUR 124,800.00 |
21.12.22 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | EUR 1,432,800.00 |
06.12.22 | Maennig, Prof. Dr. Wolfgang | Supervisory board | Buy | EUR 72,745.31 |
05.12.22 | Carpio GmbH | Close relation | Buy | EUR 73,826.53 |
DE0005659700
LEI391200EUDABLUKXCKG48
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryDZ Bank AG Deutsche Zentral-Genossenschaftsbank
Listed Stock ExchangeSDAX
TecDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.